APA (7th ed.) Citation

E, E., E, K., M, G., D, C., M, R., I, N., . . . E, T. (2018). Circulating Soluble Receptor Activator of Nuclear Factor Kappa B Ligand and C-C Motif Ligand 3 Correlate With Survival in Patients With Waldenström Macroglobulinemia. Clinical lymphoma, myeloma & leukemia, 18(6), 431. https://doi.org/10.1016/j.clml.2018.03.010

Chicago Style (17th ed.) Citation

E, Eleutherakis-Papaiakovou, et al. "Circulating Soluble Receptor Activator of Nuclear Factor Kappa B Ligand and C-C Motif Ligand 3 Correlate With Survival in Patients With Waldenström Macroglobulinemia." Clinical Lymphoma, Myeloma & Leukemia 18, no. 6 (2018): 431. https://doi.org/10.1016/j.clml.2018.03.010.

MLA (9th ed.) Citation

E, Eleutherakis-Papaiakovou, et al. "Circulating Soluble Receptor Activator of Nuclear Factor Kappa B Ligand and C-C Motif Ligand 3 Correlate With Survival in Patients With Waldenström Macroglobulinemia." Clinical Lymphoma, Myeloma & Leukemia, vol. 18, no. 6, 2018, p. 431, https://doi.org/10.1016/j.clml.2018.03.010.